Whole lotus rhizome or defined lotus-root juice,
does it really help with Reduction of menstrual blood loss in heavy menstrual bleeding?
research showsJudgment is deferred. No eligible human trial was identified that assigned whole lotus rhizome or a defined lotus-root juice to adults with heavy menstrual bleeding and compared PBAC or objective blood loss. Classical hemostatic records, traditional use of lotus leaf for uterine bleeding, rhizome nodes, carbonized products, and combination formulas are different interventions.
ads claimDo not advertise it as a hemostatic food, a menstrual-loss or anemia treatment, or a replacement for hormonal or other standard gynecologic care.
Useful facts when choosing a product
- This verdict applies only to the displayed lotus part, formulation, route, population, claim, endpoint, and comparator.
- Leaf, plumule, whole seed, rhizome, node, tea, extract, food, juice, and combination products are not interchangeable.
- Caution. Food-use experience does not establish the safety of therapeutic-dose lotus-root juice. A human anaphylaxis case involving lotus root has been reported (PMID 32232879), while incidence, dose, cooking form, pregnancy, lactation, kidney or liver disease, and interactions with anticoagulants or antiplatelets remain unverified.
Chamgap Semantic Classification Code
Candidate index · review held
F.lotus-rhizome.oral-food-or-juice.heavy-menstrual-bleeding-pbac.reduce.UNKFoods and beverages > Whole lotus rhizome > Food or juice > Heavy-menstrual-bleeding PBAC or blood loss > Reduction claim > Comparator unknown
This is separated from the cough and sputum claim in verdict 1965. Permanent issuance is held because no eligible human study directly tested whole lotus root or juice for menstrual blood loss. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
Exact Claim Classification
These independent facets prevent evidence from different forms, routes, populations, effects, and comparators from being mixed.
| Intervention class | F · Food, ingredient, or beverage |
|---|---|
| Canonical ingredient or intervention | Whole lotus rhizome or lotus-root juice |
| Source or part used | Whole edible underground rhizome of Nelumbo nucifera; nodes and carbonized products excluded |
| Formulation or processing | Whole food or defined lotus-root juice; no eligible trial formulation verified |
| Route | Oral food intake |
| Dose | Unverified (no eligible human trial) |
| Duration | Unverified (no eligible human trial) |
| Population | Adults with heavy menstrual bleeding |
| Effect or condition | Reduced menstrual blood loss |
| Primary endpoint | Unverified; intended endpoint is PBAC or objective menstrual blood loss |
| Comparator | Unverified (no eligible human trial) |
| Duplicate-detection key | Whole lotus rhizome or lotus-root juice|Whole food or defined lotus-root juice; no eligible trial formulation verified|Oral food intake|Adults with heavy menstrual bleeding|Reduced menstrual blood loss|Unverified (no eligible human trial) |
What the research actually shows
PubMed and ClinicalTrials.gov were searched using combinations of Nelumbo, lotus root, rhizome, juice, menorrhagia, heavy menstrual bleeding, and PBAC; a human antioxidant root trial, traditional-use reviews, and a human allergy case were separated by endpoint and safety role.
Why this is classified as ?
The retained search did not identify an eligible human trial directly linking whole lotus root or its juice to menstrual blood loss. Related human studies and harm reports are distinguished from direct comparative efficacy evidence. The ? rating and null score are retained; this does not prove that all human research or an effect is absent.
Counterpoint. Eating lotus root as food and repeatedly taking a therapeutic quantity of juice are different safety contracts. An evidence gap is not converted into efficacy or harmlessness.
Rejudgment record. Independent Codex cross-check — One exact plant part, formulation, population, claim, endpoint, and comparator
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| In Vivo Antioxidant Properties of Lotus Root and Cucumber: A Pilot Comparative Study in Aged Subjects | Randomized food-comparison pilot in older adults. | Older adults; exact randomized and completed denominators unverified in the retained record. | Academic study; actual funding and conflicts of interest unverified in the retained record. | Oxidative-stress and DNA-damage markers, not menstrual blood loss. | No menstrual-blood-loss outcome reported. | Human lotus-root study, but the population, claimed benefit, and endpoint do not match. |
| Phytochemical Profile and Biological Activity of Nelumbo nucifera | Narrative review of traditional use and preclinical research. | No clinical participants enrolled in this review. | Academic review; actual funding and conflicts of interest unverified in the retained record. | Traditional records of haemostatic use and metrorrhagia. | Does not provide clinical PBAC or objective menstrual-blood-loss results; this is not evidence of a null treatment effect. | Traditional-use records, not a randomized trial of whole lotus-root juice. |
| Case of anaphylaxis due to lotus root | Human case report of anaphylaxis after lotus-root ingestion. | One case; exact dose and preparation unverified. | Case report; funding and conflict-of-interest details unverified. | Allergy safety, not efficacy for heavy menstrual bleeding. | A human case of anaphylaxis associated with lotus-root ingestion. | Included only as safety evidence; excluded from efficacy evidence. |
Receipt — 3 References
Retained evidence-access date: 2026-09-08. This correction checked record consistency; it did not reverify every original source or recertify the grade.
This correction by: Codex · Evidence date: 2026-09-08 · Corrections: 1
Correction log — 1
Corrections applied to this verdict, in chronological order. Changes are logged, not erased.
- 2026-09-14 · Editorial correction and legacy-grade review notice — Translated 18 English evidence fields and citation details; distinguished related human research from an unverified direct efficacy trial. Grade and score are retained, not certified as a new final assessment. (grade ? unchanged)
Cite the review status too
Legacy grade under review. New grade-card distribution is on hold.
[Chamgap] Whole Lotus Root or Juice for Heavy Menstrual Bleeding—No Direct Eligible Human Trial Was Identified — legacy ? · score not listed, under review. https://chamgap.com/en/verdicts/womens/whole-lotus-rhizome-juice-heavy-menstrual-bleeding/ · CC BY 4.0What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.